Why is PPGN.SW stock falling pre-market today?

PPGN.SW stock fell due to heavy selling pressure, a large pre-market volume of **218,822**, and price dipping from **CHF26.65** to **CHF24.30**. Short-term technical weakness and negative earnings per share **-0.94** amplified the move.

What are the key support and resistance levels for PPGN.SW stock?

Key support is **CHF23.30** and immediate resistance is **CHF26.40**. The 50-day average sits at **CHF26.88** and the 200-day average at **CHF24.68**, which traders should monitor.

What does Meyka AI forecast for PPGN.SW stock?

Meyka AI's forecast model projects a yearly price of **CHF31.95**, implying a **31.48%** upside from the current **CHF24.30**. Forecasts are model-based projections and not guarantees.

Is PPGN.SW stock a buy after the decline?

Meyka AI assigns a **B (HOLD)** grade based on mixed metrics. Weak free cash flow and negative EPS suggest caution. Consider earnings and cash flow improvement before buying.

CH Stocks

PPGN.SW PolyPeptide Group AG (SIX) down 8.82% pre-market 14 Mar 2026: watch CHF23.30 support

ByHuzaifa Zahoor March 14, 2026March 14, 2026

PPGN.SW stock opened the pre-market session down 8.82%, trading at CHF24.30 on 14 Mar 2026 after an opening print of CHF26.40. Volume is elevated at 218,822 shares versus an average of 66,222, signalling heavy selling ahead of the Swiss session on the SIX exchange. The one-day decline follows a recent slide from the 50-day average of CHF26.88 and pushes price close to the intraday low CHF23.30. We assess fundamentals, technicals and Meyka AI model forecasts to explain why PolyPeptide Group AG is a top loser in pre-market trade